Alpha Cognition Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Alpha Cognition Inc. (ACOG) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $979.80 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2025-03-31
- Alpha Cognition Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-12-31 was $62.65K, a 86.68% decline year-over-year.
- Alpha Cognition Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-09-30 was $193.74K, a 72.21% decline year-over-year.
- Alpha Cognition Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-12-31 was $470.16K.
- Alpha Cognition Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-09-30 was $697.07K.
- Alpha Cognition Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $979.80K, a 58.65% decline from fiscal 2023.
- Alpha Cognition Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $2.37M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2024-12-31 | $62.65K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $256.39K derived: sum of 2 quarters · filed 2025-03-31 | $979.80K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $193.74K 10-Q · filed 2024-11-14 | $917.15K 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $470.16K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.17M derived: sum of 2 quarters · filed 2025-03-31 | $2.37M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $697.07K 10-Q · filed 2024-11-14 | $1.90M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |